Trials / Completed
CompletedNCT00456729
Malabsorption as a Cause of Iron Treatment Failure in Infants
Malabsorption as a Cause of Iron Treatment Failure in Infants - A Clinical Observational Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- All
- Age
- 6 Months – 4 Years
- Healthy volunteers
- Not accepted
Summary
Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metronidazole | |
| PROCEDURE | Blood tests |
Timeline
- Start date
- 2006-05-01
- Completion
- 2006-07-01
- First posted
- 2007-04-05
- Last updated
- 2007-04-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00456729. Inclusion in this directory is not an endorsement.